Publications scientifiques de l’équipe
Liste de publications récentes par domaine:
État de mal épileptique
Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trial. Sharshar T, Porcher R, Asfar P, Grimaldi L, Jabot J, Argaud L, Lebert C, Bollaert PE, Harlay ML, Chillet P, Maury E, Santoli F, Blanc P, Sonneville R, Vu DC, Rohaut B, Mazeraud A, Alvarez JC, Navarro V, Clair B, Outin H; Valse investigators and for the Groupe d’Explorations Neurologiques en Reanimation (GENER). Crit Care. 2023 Jan 9;27(1):8.
Clinico-biological markers for the prognosis of status epilepticus in adults. Hanin A, Demeret S, Lambrecq V, Rohaut B, Marois C, Bouguerra M, … , Navarro V. J Neurol. 2022.
Management Of Refractory Status Epilepticus: An International COhort stuDy (MORSE CODe) Analysis of Patients Managed in the ICU.
Chiu WT, Campozano V, Schiefecker A, Rodriguez DR, Ferreira D, Headlee A, …, Claassen J. Neurology. 2022.
Neuron Specific Enolase, S100-beta protein and progranulin as diagnostic biomarkers of status epilepticus. Hanin A, Denis JA, Frazzini V, Cousyn L, Imbert-Bismut F, Rucheton B, …, Demeret S, Navarro V. J Neurol. 2022 Jul;269(7):3752-3760.
Not all patients with convulsive status epilepticus intubated in pre-hospital settings meet the criteria for refractory status epilepticus. Zeidan S, Rohaut B, Outin H, Bolgert F, Houot M, Demoule A, …, Navarro V, Demeret S. Seizure. 2021 May;88:29-35.
Toutes nos publications sur l’état de mal épileptique
Encéphalites
Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact. de Montmollin E, Dupuis C, Jaquet P, Sarton B, Sazio C, Susset, …, Sonneville R; ENCEPHALITICA Study Group. Crit Care Med. 2022 Jul 1;50(7):e643-e648.
Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: a multicenter cohort study. Jaquet P, de Montmollin E, Dupuis C, Sazio C, Conrad M, Susset V, Demeret S, … , Sonneville R; ENCEPHALITICA study group. Intensive Care Med. 2019 Aug;45(8):1103-1111.
Encéphalopathies métaboliques [Metabolic encephalopathies]. Marois C, Quirins M, Hermann B, et al. Rev Med Interne. 2019;40(2):88–97.
An anti-NMDA receptor encephalitis mimicking an HIV encephalitis. Haneche F, Demeret S, Psimaras D, Katlama C, Pourcher V. Clin Immunol. 2018 Aug;193:10-11.
Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care. de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N, … , Sonneville R; ENCEPHALITICA Study Group. Am J Respir Crit Care Med. 2017 Feb 15;195(4):491-499.
Toutes nos publications liées aux encéphalites
Myasthénie
Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial. Sharshar T, Porcher R, Demeret S, Tranchant C, Gueguen A, Eymard B, … , Clair B; MYACOR Study Group. JAMA Neurol. 2021 Apr 1;78(4):426-433.
Home-based exercise in autoimmune myasthenia gravis: A randomized controlled trial. Birnbaum S, Porcher R, Portero P, Clair B, Demeret S, Eymard B, … , Sharshar T; MGEX Study Group. Neuromuscul Disord. 2021 Aug;31(8):726-735.
Status dissociatus and disturbed dreaming in a patient with Morvan syndrome plus myasthenia gravis. Abgrall G, Demeret S, Rohaut B, Leu-Semenescu S, Arnulf I. Sleep Med. 2015 Jul;16(7):894-6.
Regulatory B cells in myasthenia gravis are differentially affected by therapies. Yilmaz, V., Maillard, S., Truffault, F., Bolgert, F., Behin, A., Regnard, J. F., … Le Panse, R. Ann Clin Transl Neurol. 2018;5(11):1408–1414.
Neuromuscul Disord. Resistant myasthenia gravis and rituximab: A monocentric retrospective study of 28 patients. Afanasiev V, Demeret S, Bolgert F, Eymard B, Laforêt P, Benveniste O. Neuromuscul Disord. 2017 Mar;27(3):251-258.
Toutes nos publications liées à la Myasthénie
Syndrome de Guillain Barré (polyradiculonévrite aiguë)
Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection? Karnam A, Stephen-Victor E, Das M, Magy L, Vallat JM, Bolgert F, … , Bayry J. Autoimmun Rev. 2019 Jun;18(6):632-633.
Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013). Delannoy A, Rudant J, Chaignot C, Bolgert F, Mikaeloff Y, Weill A. J Peripher Nerv Syst. 2017 Mar;22(1):51-58.
Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy. Maddur MS, Stephen-Victor E, Das M, Prakhar P, Sharma VK, Singh V, … , Bayry J. J Neuroinflammation. 2017 Mar 20;14(1):58.
Post-traumatic stress symptoms in Guillain-Barré syndrome patients after prolonged mechanical ventilation in ICU: a preliminary report. Le Guennec L, Brisset M, Viala K, Essardy F, Maisonobe T, Rohaut B, … , Weiss, N. Journal of the peripheral nervous system. 2014. 19(3), 218–223.
Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome. Cochen V, Arnulf I, Demeret S, Neulat ML, Gourlet V, Drouot X, … , Bolgert F. Brain. 2005 Nov;128(Pt 11):2535-45.
Toutes nos publications liées au Syndrome de Guillain Barré
Comas, troubles de la conscience
Description and Outcome of Severe Hypoglycemic Encephalopathy in the Intensive Care Unit. Sangare A, Marois C, Perlbarg V, Pyatigorskaya N, Valente M, Zyss J, Borden A, Lambrecq V, Le Guennec L, Sitt J, Weiss N, Rohaut B, Demeret S, Puybasset L, Demoule A, Naccache L. Neurocrit Care. 2023 Apr;38(2):365-377.
EEG lexicality effect predicts clinical outcome in disorders of consciousness. Ben Salah A, Marois C, Sangare A, Valente M, Sitt J, Rohaut B, Naccache L. Ann Neurol. 2023 Apr;93(4):762-767.
Sangare A, Rohaut B, Borden A, Zyss J, Velazquez A, Doyle K, Naccache L, Claassen J. A Novel Approach to Screen for Somatosensory Evoked Potentials in Critical Care. Neurocrit Care. 2023 Mar 29.
Ethics Along the Continuum of Research Involving Persons with Disorders of Consciousness. Lewis A, Young MJ, Rohaut B, Jox RJ, Claassen J, Creutzfeldt CJ, Illes J, Kirschen M, Trevick S, Fins JJ; and The Curing Coma Campaign and its Contributing Members. Neurocrit Care. 2023 Mar 28.
Importance, limits and caveats of the use of "disorders of consciousness" to theorize consciousness. Hermann B, Sangaré A, Munoz-Musat E, Salah AB, Perez P, Valente M, Faugeras F, Axelrod V, Demeret S, Marois C, Pyatigorskaya N, Habert MO, Kas A, Sitt JD, Rohaut B, Naccache L. Neurosci Conscious. 2022 Feb 16;2021(2):niab048.
Toutes nos publications liées aux troubles de la conscience
Encéphalopathies
Neurological complications occurring after liver transplantation: Role of risk factors, hepatic encephalopathy, and acute (on chronic) brain injury. Weiss N, Thabut D. Liver Transpl. 2019 Mar;25(3):469-487.
Magnetic resonance spectroscopy: A surrogate marker of hepatic encephalopathy? Hermann B, Rudler M, Galanaud D, Thabut D, Weiss N. J Hepatol. 2019 Nov;71(5):1055-1057. doi: 10.1016/j.jhep.2019.07.008.
Understanding hepatic encephalopathy. Weiss N, Jalan R, Thabut D. Intensive Care Med. 2018 Feb;44(2):231-234.
Peak hyperammonemia and atypical acute liver failure: The eruption of an urea cycle disorder during hyperemesis gravidarum. Weiss N, Mochel F, Rudler M, Demeret S, Lebray P, Conti F, … , Thabut D. J Hepatol. 2017 Sep 20. pii: S0168-8278(17)32289-4.
Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. Weiss N, Barbier Saint Hilaire P, Colsch B, Isnard F, Attala S, … , Junot C. J Hepatol. 2016 Dec;65(6):1120-1130. doi: 10.1016/j.jhep.2016.07.046.
Toutes nos publications liées à l’encéphalopathie
COVID-19
Neuro-Psychological Outcome of ICU-Admitted COVID-19 Patients Presenting With CNS Complications. Pelle J, Nedelec T, Marois C; Coco Neurosciences study group. Crit Care Med. 2023 Apr 1;51(4):e101-e103.
Comparison of Clinical Profiles and Mortality Outcomes Between Influenza and COVID-19 Patients Invasively Ventilated in the ICU: A Retrospective Study From All Paris Public Hospitals From 2016 to 2021. Marois C, Nedelec T, Pelle J, Rozes A, Durrleman S, Dufouil C, Demoule A. Crit Care Explor. 2022 Jul 25;4(7):e0737.
Endothelial cell biomarkers in critically ill COVID-19 patients with encephalitis. Altmayer V, Ziveri J, Frère C, Salem JE, Weiss N, Cao A, …, Le Guennec L. J Neurochem. 2022 Jun;161(6):492-505.
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. Mazeraud A, Jamme M, Mancusi RL, Latroche C, Megarbane B, Siami S, Z, … , Sharshar T. Lancet Respir Med. 2021 Nov 11:S2213-2600(21)00440-9.
Association of Clinical, Biological, and Brain Magnetic Resonance Imaging Findings With Electroencephalographic Findings for Patients With COVID-19. Lambrecq V, Hanin A, Munoz-Musat E, Chougar L, Gassama S, … ,Navarro V; Cohort COVID-19 Neurosciences (CoCo Neurosciences) Study Group. JAMA Netw Open. 2021 Mar 1;4(3):e211489.
Severe COVID-19-related encephalitis can respond to immunotherapy. Cao A, Rohaut B, Le Guennec L, Saheb S, … , Demeret S. Brain. 2020 doi:10.1093/brain/awaa337
Toutes nos publications liées à la COVID-19